Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders

Journal of Neuroscience Research

Volumn 85, Issue 5, 2007, Pages 1143-1148

  Nicolson, Garth L ^a   Gan, Robert ^a   Nicolson, Nancy L ^a   Haier, Joerg ^a,b  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Autism; Chlamydia pneumoniae; HHV 6 virus; Infection; Mycoplasma species

Indexed keywords

ADOLESCENT; ARTICLE; AUTISM; BACTERIAL INFECTION; BLOOD ANALYSIS; CHILD; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; INFECTION RISK; INFECTION SENSITIVITY; MALE; MYCOPLASMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SUPERINFECTION; VIRUS INFECTION;

ADOLESCENT; AUTISTIC DISORDER; BRAIN; CALIFORNIA; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMORBIDITY; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MYCOPLASMA; MYCOPLASMA INFECTIONS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; ROSEOLOVIRUS INFECTIONS;

EID: 34147206292     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21203     Document Type: Article

References (41)

1. Baseman J, Tully J. 1997. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 3:21-32.
2. Berg S, Lueneberg E, Frosch M. 1996. Development of an amplification and hybridization assay for the specific and sensitive detection of Mycoplasma fermentans DNA. Mol Cell Probes 10:7-14.
3. Bernet C, Garret M, de Barbeyrac B, Bebear C, Bonnet J. 1995. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol 27:2492-2496.
4. Berney TB. 2000. Autism - an evolving concept. Br J Psychiatry 176:20-25.
5. Braun DK, Dominguez G, Pellett PE. 1997. Human herpesvirus-6. Clin Microbiol Rev 10:521-567.
6. Buttram HE. 2004. Vaccine scene 2004 update: still MMR vaccination, mercury and aluminum. Med Veritas 1:130-135.
7. Campadelli-Fiume G, Mirandela P, Menetti L. 1999. Human herpesvirus-6: an emerging pathogen. Emerg Infect Dis 5:353-366.
8. Chia JKS, Chia LY. 1999. Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome. Clin Infect Dis 29:452-453.
9. Ciaranello AL, Ciaranello RD. 1995. The neurobiology of infantile autism. Annu Rev Neurosci 18:101-128.
10. Colborn T. 2004. Neurodevelopment and endocrine disruption. Environ Health Perspect 112:944-949.
11. Davidson PW, Myers GJ, Weiss B. 2004. Mercury exposure and child development outcomes. Pediatrics 113:1023-1029.
12. Eppright TD, Sanfacon JA, Horwitz EA. 1996. Attention deficit hyperactivity disorder, infantile autism and elevated blood-lead: a possible relationship. Mol Med 93:136-138.
13. Folstein SE, Rosen-Sheidley B. 2001. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2:943-955.
14. Geier DA, Geier MR. 2004. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit 10:133-139.
15. Haley B. 2005. Hypothesis. Thimerosal in mandated vaccinations is the major etiological agent in the recent increase in autism and attention deficit/hyperactive disorder. Med Veritas 2:438-440.
16. Horning M, Weissenbock H, Horscroft N, Lipkin WI. 1999. An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci U S A 96:12102-12107.
17. Huang W, See D, Tiles J. 1998. The prevalence of Mycoplasma incognitus in the peripheral blood mononuclear cells of normal controls or patients with AIDS or chronic fatigue syndrome. J Clin Microbiol 231:457-467.
18. Jackson MJ, Garrod PJ. 1978. Plasma zinc, copper and amino acid levels in the blood of autistic children. J Autism Child Schizophr 8:203-208.
19. Kanner L. 1943. Autistic disturbances of affective contact. Nerv Child 2:217-250.
20. Keen D, Ward S. 2004. Autistic spectrum disorder. Autism 8:39-58.
21. Kidd P. 2002. Autism, and extreme challenge to integrative medicine. Part II: medical management. Altern Med Rev 7:472-499.
22. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. 2005. Autistic disorder and viral infections. J Neurovirol 11:1-10.
23. Lipkin WI, Hornig M. 2003. Microbiology and immunology of autism spectrum disorders. Novartis Found Symp 251:129-143.
24. Lord C, Pickles A, McLennan J, Rutter M, Bregman J, Folstein S, Fombonne E, Leboyer M, Minshew N. 1997. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 27:501-517.
25. Nasralla M, Haier J, Nicolson GL. 1999. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia. Eur J Clin Microbiol Infect Dis 18:859-865.
26. Nasralla MY, Haier J, Nicolson NL, Nicolson GL. 2000. Examination of mycoplasmas in blood of 565 chronic illness patients by polymerase chain reaction. Int J Med Biol Environ 28:15-23.
27. Nicolson GL, Berns P, Nasralla M, Haier J, Pomfret J. 2002. High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with amyotrophic lateral sclerosis (ALS). J Clin Neurosci 9:525-529.
28. Nicolson GL, Gan R, Haier J. 2003a. Multiple co-infections (Mycoplasma, Chlamydia, human herpesvirus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. Acta Pathol Microbiol Immunol Scand 111:557-566.
29. Nicolson GL, Nasralla M, Gan R, Haier J, De Meirleir K. 2003b. Evidence for bacterial (Mycoplasma, Chlamydia) and viral (HHV-6) coinfections in chronic fatigue syndrome patients. J Chronic Fatigue Syndr 11:7-20.
30. Nicolson GL, Nasralla M, Nicolson NL, Haier J. 2003c. High prevalence of mycoplasmal infections in symptomatic (chronic fatigue syndrome) family members of mycoplasma-positive gulf war illness patients. J Chronic Fatigue Syndr 11:21-36.
31. Nicolson GL, Gan R, Haier J. 2005a. Evidence for Brucella spp. and Mycoplasma spp. coinfections in blood of chronic fatigue syndrome patients. J Chronic Fatigue Syndr 12:5-17.
32. Nicolson GL, Nicolson GL, Gan R, Haier J. 2005b. Chrome mycoplasmal infections in Gulf War Veterans' children and autism patients. Med Veritas 2:383-387.
33. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. 2002. Prevalence of mycoplasmal infections in European CFS patients. Examination of four Mycoplasma species. FEMS Immunol Med Microbiol 34:209-214.
34. Pilowsky T, Yirmiya N, Shulman C, Dover R. 1998. The Autism Diagnostic Interview - Revised and the Childhood Autism Rating Scale: differences between diagnostic systems and comparison between genders. J Autism Dev Disord 28:143-151.
35. Takahashi H, Arai S, Tanaka-Taya K, Okabe N. 2001. Autism and infection/immunization episodes in Japan. Jpn J Infect Dis 54:78-79.
36. Thornton D. 1986. A survev of mycoplasma detection in vaccines. Vaccine 4:237-240.
37. Van Bourgondien ME, Marcus LM, Schopler E. 1992. Comparison of DSM-III-R and childhood autism rating scale diagnoses of autism. J Autism Dev Disord 22:493-506.
38. Veenstra-Vanderweele J, Cook E Jr, Lombroso PJ. 2003. Genetics of childhood disorders. XLVI. Autism, part 5, genetics of autism. J Am Acad Child Adolesc Psychiatry 42:116-118.
39. Wilkerson DS, Volpe AG, Dean RS, Titus JB. 2002. Perinatal complications as predictors of infantile autism. Int J Neurosci 112:1085-1098.
40. Wing L, Leekam SR, Libby SJ, Gould SJ, et al. 2002. The diagnostic interview for social and communication disorders: background, interrater reliability and clinical use. J Child Psychol Psychiatry 43:307-325.
41. Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T. 2003. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord 33:355-459.